Who Paid My Doc
Unituxin
Drug Oncology
NDC 66302-014-01
General payments
$3,497
Research payments
$1,881,579
Through program year 2024, $3,497 in general payments and $1,881,579 in research payments were reported against Unituxin (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $63,585 | 2 |
| 2023 | General | $655 | 11 |
| 2023 | Research | $263,936 | 7 |
| 2022 | General | $668 | 19 |
| 2022 | Research | $617,009 | 19 |
| 2021 | General | $916 | 49 |
| 2021 | Research | $164,190 | 20 |
| 2020 | General | $1,257 | 23 |
| 2020 | Research | $772,860 | 111 |
Breakdown
The top 5 of 7 recipients; each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
102 general · 159 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.